8-K: Health In Tech Announces Full Year 2024 Financial Results, Reports Revenue Growth and Strategic Investments

Health In Tech reports $19.5 million in total audited revenue for 2024, marking a 1.8% year-over-year increase, alongside strategic investments in technology and infrastructure.

Summary

• Health In Tech announced its financial results for the fourth quarter and full year ended December 31, 2024.
• Total audited revenue for 2024 was $19.5 million, a 1.8% increase year-over-year.
• The first two months of 2025 saw unaudited revenue of approximately $5.7 million, exceeding Q1 2024 revenue and showing over 50% year-over-year growth compared to the first two months of 2024.
• Cash and cash equivalents were $7.8 million as of December 31, 2024.
• Total current liabilities were $2.1 million as of December 31, 2024.
• Gross margin for 2024 was 79.2%, compared to 88.0% in 2023.
• Income from continuing operations, net of income taxes, was $0.7 million in 2024, compared to $2.5 million in 2023.
• Adjusted EBITDA was $2.3 million in 2024, compared to $4.8 million in 2023.
• The company completed its IPO in December 2024, raising $9.2 million in gross proceeds before deducting underwriting discounts and commissions.
• Health In Tech is launching a mid-sized business underwriting solution in 2025, targeting employers with more than 150 employees.
• The company is also introducing a new Spec & Agg stop-loss product to streamline claims processing.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While revenue increased, profitability metrics declined. The successful IPO and expansion plans provide a positive outlook, but the decreased margins and income raise concerns.

Positives

• Health In Tech achieved a 1.8% increase in total revenue for 2024, reaching $19.5 million.
• Cash reserves are strong at $7.8 million as of December 31, 2024.
• The company successfully completed its IPO in December 2024, raising $9.2 million.
• The company is expanding its product offerings to include mid-sized businesses and a new stop-loss product.
• The first two months of 2025 show strong revenue growth, exceeding Q1 2024 revenue and showing over 50% year-over-year growth compared to the first two months of 2024.

Negatives

• Gross margin decreased from 88.0% in 2023 to 79.2% in 2024.
• Income from continuing operations decreased from $2.5 million in 2023 to $0.7 million in 2024.
• Adjusted EBITDA decreased from $4.8 million in 2023 to $2.3 million in 2024.
• The number of enrolled employees (EEs) billed was 18,348, compared to 21,213 in the same period of 2023.
• The number of business clients serviced was 890, compared to 1,002 in the same period of 2023.

Risks

• The company's forward-looking statements are subject to risks, uncertainties, and assumptions that could affect actual results.
• Reliance on third-party AI technology could pose a risk if the technology fails to perform as expected.
• Competition in the Insurtech market could impact the company's growth and profitability.
• The company's ability to successfully launch and scale new products and services is subject to execution risk.

Future Outlook

Health In Tech anticipates continuing to invest in automation and expand into new markets, remaining committed to delivering innovative, value-driven solutions that transform self-funded healthcare.

Management Comments

• '2024 was a transformative year for Health In Tech as we successfully completed our IPO, expanded our product offerings, and made strategic investments in technology and infrastructure,' said Tim Johnson, CEO of Health In Tech.
• Mr. Johnson continued: 'In 2025, we are accelerating execution and expanding our reach.'

Industry Context

Health In Tech's focus on streamlining processes and leveraging AI aligns with the broader Insurtech trend of using technology to improve efficiency and reduce costs in the healthcare industry.

Comparison to Industry Standards

• It is difficult to compare Health In Tech directly to industry standards without knowing the specific metrics of comparable companies.
• However, companies like GoHealth and SelectQuote operate in similar spaces, focusing on technology-driven solutions for health insurance.
• Their revenue growth and profitability metrics could provide a benchmark for Health In Tech's performance.
• Additionally, the company's gross margin of 79.2% can be compared to other software and technology-enabled service companies in the healthcare sector to assess its competitiveness.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the decrease in profitability metrics despite the revenue increase.
• Employees may be affected by the company's strategic investments in technology and infrastructure.
• Customers could benefit from the company's expanded product offerings and improved efficiency.
• Suppliers and partners may see increased opportunities as the company expands into new markets.

Next Steps

• The company plans to fully launch its mid-sized business underwriting solution.
• Health In Tech will continue to invest in automation and expand into new markets.
• The company will host a conference call to discuss the financial results on March 17, 2024, at 5:00 p.m. (ET).

Key Dates